Abstract

Human stem cell-derived cells and tissues hold considerable potential for applications in regenerative medicine, disease modeling and drug discovery. The generation, culture and differentiation of stem cells in low-volume, automated and parallelized microfluidic chips hold great promise to accelerate the research in this domain. Here, we show that we can differentiate human embryonic stem cells (hESCs) to early cardiac mesodermal cells in microfluidic chambers that have a volume of only 30 nanoliters, using discontinuous medium perfusion. 64 of these chambers were parallelized on a chip which contained integrated valves to spatiotemporally isolate the chambers and automate cell culture medium exchanges. To confirm cell pluripotency, we tracked hESC proliferation and immunostained the cells for pluripotency markers SOX2 and OCT3/4. During differentiation, we investigated the effect of different medium perfusion frequencies on cell reorganization and the expression of the early cardiac mesoderm reporter MESP1mCherry by live-cell imaging. Our study demonstrates that microfluidic technology can be used to automatically culture, differentiate and study hESC in very low-volume culture chambers even without continuous medium perfusion. This result is an important step towards further automation and parallelization in stem cell technology.

Highlights

  • Stem cell technology advances the generation and controlled differentiation of stem cells, including human adult stem cells, human embryonic stem cells and human induced pluripotent stem cells

  • We focus on validating our chip for culturing and differentiating human embryonic stem cells (hESCs) to cardiac mesodermal cells as the first step towards addressing this complex problem

  • In this article we showed that we can differentiate hESCs to cardiac mesoderm cells in 30 nL microchambers using different discontinuous medium perfusion intervals

Read more

Summary

Introduction

Stem cell technology advances the generation and controlled differentiation of stem cells, including human adult stem cells, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Stem cells have enabled new strategies for use in fields like regenerative medicine, disease modeling and drug discovery. Stem cell technology enables the Andries D. van der Meer and Mathieu Odijk have contributed to this work. Directing stem cell fate of human pluripotent stem cells (hPSCs) is essentially achieved by emulating embryogenesis and requires creating a highly dynamic and spatially heterogenous microenvironment. Reliably and reproducibly generating cell lineages with a high degree of cell commitment presents an enormous challenge. Significant progress has been made to overcome this challenge by

30 Page 2 of 14
Results and discussion
30 Page 4 of 14
HESC population change depending on different medium exchange intervals
Pluripotency staining of hESCs in chambers
Cell re‐organization during differentiation to cardiac mesodermal cells
30 Page 6 of 14
MESP1 expression on day 3
30 Page 8 of 14
Conclusion and outlook
Chip fabrication
30 Page 10 of 14
Automation set‐up
Microscope incubation system
HESC culture and differentiation protocol in well plates
MFBB surface functionalization and hESC loading
Image analysis for hESC counting during proliferation
Statistical analysis
HESC fixation and staining
30 Page 12 of 14
HESC differentiation in chip
4.10 Quantification of MESP1 expressing cells on day 3 of differentiation
4.11 MESP1 live cell imaging
Findings
30 Page 14 of 14
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call